Clinical Diagnosis

The trial is evaluating AURN001, a combination cell therapy product comprised of neltependocel (allogeneic human corneal endothelial cells [CECs]) and Y-27632 for the treatment of corneal edema secondary to corneal endothelial dysfunction.

Joseph Izatt was a skilled researcher and inventor who played a foundational role in the development of optical coherence tomography.

CRISPR manipulation presents opportunities and challenges.

Andrew Lee, MD, and Andrew Carey, MD, sit down on another episode of the NeuroOp Guru to discuss Susac syndrome, and how leakage on fluorescein angiogram might be the most sensitive marker of activity of disease.

Alice Epitropoulos, MD, discusses the importance of considering ocular surface health in cataract surgery patients.

Ophthalmologist shares pearls from recent roundtable discussion on topic.

Physicians note the impact of prism lenses can be life-changing for patients.

Research can drive opportunities for patients with rare diseases

Slit lamp evaluation can provide valuable information for treatment course.

Ophthalmic data are well suited to the demands of regulatory-grade use cases.

Resolution of macular leakage is an early biomarker of vascular stability.

Leaders must confront issues perpetuating unequal access, unfair practices.

In this podcast episode, Ophthalmology Times' co-chief medical editors Peter J. McDonnell, MD, and Neda Shamie, MD, delve into the clinical nuances of Demodex blepharitis. Through personal anecdotes, they stress its underrecognized gravity and discuss diagnostic cues like collarettes. The experts share their enthusiasm for improved treatments, echoing the transformative impact seen in dry eye care.

Condition is linked to longer resolution times, worse outcomes

Surgeon discusses latest trends for treating cornea.

According to Horizon Therapeutics, the analysis shows subclinical spinal cord lesions were associated with future NMOSD attacks. The analysis was being presented at the 9th Congress of the European Academy of Neurology in Budapest.

William B. Trattler, MD, highlights some of the novel therapies for dry eye that have recently been approved by the FDA, along with various treatment approaches that are in development.

Dual therapy may slow the progression of condition.

Medical, surgical management can be important tools.

John D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.

At the IKA Keratoconus Symposium, Justin Schweitzer, OD, FAAO, presented on establishing the keratoconus diagnosis alongside Kourtney Houser, MD.

President and CEO of the International Keratoconus Academy Andrew Morgenstern, OD, FAAO, FNAP, shares some snippets about the live white paper development session and the patient Q&A happening at the inaugural IKA Keratoconus Symposium.

Uri Soiberman, MD, shares some key takeaways from his presentation at the inaugural IKA Keratoconus Symposium.